GlassScriptPhysician profile
Christopher J Parot
NPI 1487713160
$6,558.62
in general payments reported to CMS, 2019-2025
19 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $355 · 2021: $1,228 · 2022: $1,086 · 2023: $1,010 · 2024: $859 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,739 · Entertainment: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,738.82 |
| Entertainment | $360.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,407.44 | 2022-2025 | Infuse, Miebo, Xiidra |
| Coopervision INC. | $1,229.13 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $852.03 | 2021-2025 | Precision 1, Precision7, Total30 |
| Optos, INC. | $622.37 | 2021-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $519.28 | 2019-2021 | |
| Sight Sciences, INC. | $463.09 | 2019-2023 | Tearcare System |
| Notal Vision, INC. | $301.34 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $234.31 | 2021 | |
| Visioneering Technologies, INC. | $131.86 | 2019 | |
| Harrow Eye, LLC | $125.00 | 2025 | Vevye |
| Horizon Therapeutics Plc | $124.98 | 2021 | |
| Astellas Pharma US INC | $121.84 | 2025 | Izervay |
| Kala Pharmaceuticals, INC. | $118.17 | 2021 | |
| Lkc Technologies, INC. | $105.39 | 2025 | |
| Maculogix, INC. | $83.11 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $59.97 | 2024-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $24.87 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Parot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.